GlassVC
Lightstone Ventures

Lightstone Ventures

Venture capital firm · Founded 2012 · Boston, MA · Boston ↗

Lightstone Ventures is an early-stage life sciences venture firm, founded in 2012, that funds novel and disruptive therapeutics and medical technologies with a thesis-driven strategy and offices in the U.S., Ireland and Singapore.

Tier 4Basis: No AUM or fund size stated in fetched firm sources, so tier 4 on current evidence despite the firm's 2012 founding and global footprint.

Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

This profile is unclaimed. Built from public sources. If you're a partner or employee at Lightstone Ventures, you can claim it.

Claim this profileHow claiming works

Key numbers

Assets under management

Not publicly disclosed

LAST CHECKED NOV 2026

Latest fund

Lightstone Ventures III$375M · 2021

Funds

3

Check size

Not publicly disclosed

LAST CHECKED NOV 2026

Stages

SeedSeries A

Sectors

therapeuticsmedical technologylife sciences

FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG

Track record

Outcomes are recorded from public sources and attributed to the firm, not to individual partners. Shutdowns and write-offs are an ordinary part of venture investing; inclusion here is a record, not a judgment.

Hits

  • Claret Medical

    Acquired by Boston Scientific — Lightstone's Fund III announcement lists Claret Medical (acquired by Boston Scientific) among its portfolio companies.

    Source: hitconsultant.net

  • Disarm TherapeuticsAcquired by Eli Lilly

    Lightstone's Fund III announcement lists Disarm Therapeutics (acquired by Eli Lilly and Co.) among its portfolio companies.

    Source: hitconsultant.net

  • Ra PharmaAcquired by UCB

    Lightstone's Fund III announcement lists Ra Pharma (acquired by UCB) among its portfolio companies.

    Source: hitconsultant.net

  • Tizona Therapeutics

    Acquired by Gilead Sciences — Lightstone's Fund III announcement lists Tizona (acquired by Gilead Sciences) among its portfolio companies.

    Source: hitconsultant.net

Misses

Track record

No outcomes recorded yet from public sources.

Partners 6

Reputation 1

No reputation score — basis not established for this firm.

Contact

Published sources only

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

SOURCE: FIRM WEBSITE, AS PUBLISHED 2

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Lightstone Ventures. Reviews come from founders whose identity and relationship have been verified.

Write the first review

Methodology

Tier basis — No AUM or fund size stated in fetched firm sources, so tier 4 on current evidence despite the firm's 2012 founding and global footprint. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.

The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.

Source record 2

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Lightstone Ventures — provenance: GlassVC catalog census, November 2026

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Track record · Reputation

  2. [2]

    FIRM SITE · Lightstone Ventures — Firm website, as published by the firm

    LAST CHECKED NOV 2026 ↗

    ↩ cites: Website

PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026